Discover life science companies across the East of England, including biotechnology firms, CROs, research organisations and innovation hubs.
Synthetic glycan-targeted small molecules for next-generation immunotherapy
Anomer Bio is a biotechnology company developing synthetic monosaccharides and small molecule drugs that target glycans, the sugars coating cell surfaces that influence immune responses and disease. Its platform combines multi-omics data and machine learning to model how cells process sugars, enabling the design of…
Precision therapeutics targeting fibrosis using multi-omics
Forth Therapeutics develops precision medicines intended to target the cellular mechanisms driving organ fibrosis. Its discovery platform combines single-cell and spatial genomics with patient-derived tissue data, including a large human liver disease dataset. These insights help identify disease-associated cells and…
End-to-end antibody discovery and development services for global biopharma
FairJourney Biologics is a contract research organisation providing integrated antibody discovery, engineering, production and characterisation services to pharmaceutical and biotechnology companies worldwide. The company combines phage display and mammalian display technologies across immune and naïve antibody…
Organ-specific liquid biopsy tests for early cancer detection
Mursla Bio is a diagnostics company developing blood-based tests for early cancer detection using extracellular vesicle biology. Its platform isolates organ-specific extracellular vesicles from blood and applies multi-omics profiling and machine learning to identify disease biomarkers without tissue biopsy. Its lead…
Targeted oral drug delivery platform for cancer, CNS and respiratory disease
TRX Biosciences is a biotechnology company developing a targeted oral drug delivery platform, enabling therapies to reach specific organs, cells and tissues for cancer, central nervous system, respiratory and immune system diseases. The company's technology is licensed to partner companies for use in their own drug…
Specialist AAV vector manufacturer for gene therapy developers
Trisk Bio is a contract development and manufacturing organisation specialising in the production of adeno-associated virus vectors for gene therapy applications. Its intensified manufacturing processes use suspension bioreactors and chromatography-based purification to deliver high-purity AAV at scalable yields for…
Regulatory-compliant medical AI software and connected device development
Camgenium is a medical technology software company specialising in the development and deployment of AI-driven medical device software and connected hardware. Operating to ISO 13485, ISO 27001 and GxP standards, the company offers end-to-end services spanning product concept, development, production, and deployment.…
Computational chemistry software and consulting for small molecule discovery
Cresset Biomolecular Discovery is a UK software and consulting company providing computational chemistry solutions for small molecule drug discovery and design. Its patented field technology evaluates molecules using surface properties rather than 2D structural similarity, enabling virtual screening, scaffold hopping,…
AI-designed extended-expression RNA therapeutics for cardio-metabolic disease
ScionxBio, formerly Eleven Therapeutics, is a biotechnology company developing xRNA, a chemically expanded RNA modality engineered to extend protein expression from days to months. Combinatorial chemistry and deep learning are combined to design molecules with enhanced stability and reduced immune sensing, enabling…
Diverse oncology datasets for AI-driven precision medicine research
CureCollect is a life science data company sourcing multimodal oncology datasets for precision medicine and artificial intelligence research. It collaborates with hospitals and laboratories to assemble pathology images, genomic and transcriptomic data, longitudinal clinical records and treatment outcomes from diverse…
Human proteome microarrays and protein array screening services
Cambridge Protein Arrays supplies human proteome microarrays and specialist screening services for researchers. Its HuProt arrays contain thousands of full-length human proteins, enabling antibody specificity testing, autoantibody profiling and investigations of molecular interactions. Researchers can obtain arrays or…
Small-molecule drugs targeting cellular ageing and senescence
Five Alarm Bio Limited is a biotechnology company discovering small-molecule therapies for diseases associated with ageing. Its research targets chemical damage that accumulates inside cells, aiming to reinforce protective mechanisms and delay cellular senescence rather than destroy senescent cells. Candidate…
Interdisciplinary institute studying the regulatory systems of plant development
Sainsbury Laboratory Cambridge University is a research institute studying the regulatory systems underlying plant growth and development. The Laboratory combines experimental biology with computational modelling, bringing together biologists, physicists and mathematicians to understand how plant hormones, gene…
Solid form sciences and API development for drug candidates
Veranova's Cambridge site is a centre of excellence in solid form and particle engineering, operating under the Pharmorphix brand. The facility provides polymorph screening, salt selection, co-crystallisation, chiral separations, and process scale-up services to pharmaceutical and biotechnology customers. Part of…
End-to-end lateral flow immunoassay development and manufacturing
Global Access Diagnostics (GADx) is a contract developer and manufacturer of rapid lateral flow immunoassay tests for human, veterinary, and agricultural applications. Operating as a social enterprise, GADx provides end-to-end diagnostic development services from assay design and antibody development through to…
Multiomics platform for cancer biomarker discovery and diagnostics
Tagomics is a Cambridge-based biotech developing a multiomics platform for disease biomarker discovery and diagnostics. Its platform integrates genomics, epigenomics and fragmentomics with advanced bioinformatics and machine learning to identify disease-associated DNA markers from blood and other biological sources.…
Fragment and structure-based drug discovery services
Vernalis (R&D) is a Cambridge-based contract drug discovery organisation specialising in fragment-based and structure-based drug discovery. The company integrates structural biology, biophysics, NMR spectroscopy, DNA-encoded library screening, medicinal chemistry, and computational approaches to identify and progress…
CASPAROV AI platform for targets in heterogeneous cancers
Enedra Therapeutics develops targeted cancer medicines designed to address genetic diversity within solid tumours, a major cause of treatment resistance. Its CASPAROV platform combines cancer genomics, AI and functional biology to identify survival mechanisms shared across heterogeneous tumour cells. These convergent…
G-quadruplex-targeting medicines for precision cancer treatment
Genome Therapeutics is a biotechnology company developing cancer medicines that target G-quadruplex DNA structures associated with tumour biology. Its approach builds on research into non-canonical DNA folding and how these structures influence gene regulation and cancer cell vulnerabilities. The company develops…
AI platform targeting chromosomal instability across cancer
Tailor Bio is a Cambridge-based biotechnology company developing an AI-driven precision medicine platform for cancers with chromosomal instability, a genomic phenomenon present in over 80% of all cancers. Founded from research originating at the Cancer Research UK Cambridge Institute, the company develops both…